US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Gene Editing

491.81

+15.723.30%

Number of Gainers:4

Number of Losers:- -

Number of Flat:- -

PE:- -

High:507.02

Open:483.01

Low:482.63

Close:476.09

Volume:10.38M

Turnover:271.92M

Market Cap:11.10B

Float Cap:10.39B

Loading ...

Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million

Editas Medicine Announces Second Quarter 2026 Results and Business Updates

THOMSON REUTERS

Editas Medicine Q2 Basic EPS USD -0.15

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam Therapeutics (BEAM)

Analysts Offer Insights on Healthcare Companies: Waters (WAT), Beam Therapeutics (BEAM) and Green Thumb Industries (OtherGTBIF)

Clear Street Remains a Buy on Beam Therapeutics (BEAM)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4556/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":491.81247,"timestamp":1787342399999,"preClose":476.09332,"halted":0,"volume":10380296,"delay":0,"changeRate":0.033017,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":15.719147,"latestTime":"08-21 16:00:00 EDT","open":483.00705,"high":507.0229,"low":482.62756,"amount":271917693.921845,"amplitude":0.051241,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.9206,"peRate":-10.529407,"turnoverRate":0.023735,"increases":4,"decrements":0,"flats":0,"marketCap":11100480736,"floatMarketCap":10393482176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":507.0229,"amplitude":0.051241,"preClose":476.09332,"low":482.62756,"pbRate":"2.9206","latestPrice":491.81247,"volume":10380296,"delay":0,"open":483.00705,"prevYearClose":431.70972,"prevWeekClose":444.6557,"prevMonthClose":405.9402,"prevQuarterClose":517.3469,"fiveDayClose":444.6557,"twentyDayClose":398.2596,"sixtyDayClose":482.6405,"secType":"PLATE","market":"US","turnoverRate":0.023735,"peRate":-10.529407,"marketCap":11100480736,"floatMarketCap":10393482176,"timestamp":1787342399999,"nameCN":"Gene Editing"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":4,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657527677","title":"Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527677","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527677?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:02","pubTimestamp":1785960121,"startTime":"0","endTime":"0","summary":"BRIEF-Editas Medicine Q2 Net Income USD -18.23 Million Vs. IBES Estimate USD -27 MillionAug 05  - Editas Medicine Q2 operating expenses USD 30.444 million.Q2 operating income USD -18.554 millionQ2 basic EPS USD -0.15Q2 collaboration and other research and development revenue USD 11.9 millionQ2 EPS USD -0.15","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX0ZL5LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDIT","BK4556","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657342527","title":"Editas Medicine Announces Second Quarter 2026 Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657342527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657342527?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:01","pubTimestamp":1785960062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA94XR28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EDIT","BK4556","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657152736","title":"Editas Medicine Q2 Basic EPS USD -0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2657152736","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657152736?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:01","pubTimestamp":1785960061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX0ZL5LD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4556","BK4139","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652342","title":"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam Therapeutics (BEAM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652342?lang=en_us&edition=fundamental","pubTime":"2026-08-05 22:40","pubTimestamp":1785940835,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-ultragenyx-pharmaceutical-rare-and-beam-therapeutics-beam-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-ultragenyx-pharmaceutical-rare-and-beam-therapeutics-beam-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","LU0965509010.AUD","LU2087621335.USD","MEDI","HCSG","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4532","LU1430594728.SGD","XBI","LU1934455277.USD","BK4550","BBH","BK4137","LU0965509283.SGD","TMED","IE00B19Z3581.USD","LABU","RARE","BMED","BK4578","SG9999015945.SGD","LU2324357040.USD","BK4535","LU1023059063.AUD","BEAM","LU1674673428.USD","SG9999015978.USD","BIB","TBXU","XLV","GILD","IE00B7SZLL34.SGD","LU0882574055.USD","BK4568","LU1061106388.HKD","LU1839511570.USD","LU0965508806.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU0234570918.USD","IE00B3T34201.USD","LU0029874061.USD","LU1066051498.USD","BK4556","LU0320765992.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657257544","title":"Analysts Offer Insights on Healthcare Companies: Waters (WAT), Beam Therapeutics (BEAM) and Green Thumb Industries (OtherGTBIF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657257544","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657257544?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:10","pubTimestamp":1785931809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Waters (WAT), Beam Therapeutics (BEAM) and Green T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-waters-wat-beam-therapeutics-beam-and-green-thumb-industries-othergtbif-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-waters-wat-beam-therapeutics-beam-and-green-thumb-industries-othergtbif-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","LU1861559042.SGD","BK4137","LABU","LU2413666426.HKD","GB00B4LPDJ14.GBP","XBI","LU2404859741.USD","XLV","WAT","LU1721428933.USD","BK4611","BK4585","BK4535","HCSG","BK4139","LU0690374961.EUR","LU2404859667.USD","LU0029874061.USD","GB00B4QBRK32.GBP","BEAM","LU2413666699.HKD","BK4505","LU0690374615.EUR","BK4588","LU0347712357.USD","LU0128526141.USD","BK4556","BK4121","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657517142","title":"Clear Street Remains a Buy on Beam Therapeutics (BEAM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657517142","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657517142?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:35","pubTimestamp":1785922545,"startTime":"0","endTime":"0","summary":"In a report released today, William Maughan from Clear Street maintained a Buy rating on Beam Therapeutics, with a price target of $37.00. Accordin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/clear-street-remains-a-buy-on-beam-therapeutics-beam-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/clear-street-remains-a-buy-on-beam-therapeutics-beam-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4588","BK4505","LU1861558580.USD","BK4556","BK4611","BK4139","BK4585","BK4535","BEAM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":26,"code":"91000000","status":"200"}]}}